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In cultured cerebellar granule neurons, low neuronal activity triggers the intrinsic program of apoptosis, which requires protein
synthesis-dependent BAX translocation tomitochondria, a process thatmay underlie neuronal damage in neurodegeneration.However,
the mechanisms that link neuronal activity with the induction of the mitochondrial program of apoptosis remain unclear. Neuronal
pentraxin 1 (NP1) is a pro-apoptotic protein induced by low neuronal activity that is increased in damaged neurites in Alzheimer’s
disease-affected brains. Here we report that NP1 facilitates the accumulation of BAX in mitochondria and regulates mitochondrial
dynamics during apoptosis in rat andmouse cerebellar granule neurons in culture. Reduction of neuronal activity increases NP1 protein
levels in mitochondria and contributes to mitochondrial fragmentation in a Bax-dependent manner. In addition, NP1 is involved in
mitochondrial transport in healthy neurons. These results show that NP1 is targeted to mitochondria acting upstream of BAX and
uncover a novel function for NP1 in the regulation of mitochondrial dynamics and trafficking during apoptotic neurodegeneration.
Introduction
In mature neurons, low neuronal activity triggers the intrinsic
program of apoptotic cell death (D’Mello et al., 1993). One of
the proteins that links neuronal activity with the apoptotic
program in differentiated neurons is neuronal pentraxin 1
(NP1) (DeGregorio-Rocasolano et al., 2001). NP1 is predom-
inantly expressed in the nervous system (Schlimgen et al.,
1995). In previous studies, we have shown that reduction of
neuronal activity induces the synthesis of NP1 (DeGregorio-
Rocasolano et al., 2001) through a glycogen synthase kinase 3
signaling pathway (Enguita et al., 2005). The increase in NP1
occurs during the initial phase of the gene-expression-dependent
intrinsic program of apoptotic death, before neurons reach the
irreversible commitment to die. Moreover, NP1 also contributes
to synapse loss, neurite damage, and the subsequent apoptotic
toxicity induced by other apoptotic stimuli such as amyloid-
(A) in cortical neuronal cultures (Abad et al., 2006).
It is well established that the apoptosis evoked by lowneuronal
activity in cerebellar granule neurons (CGNs) requires macro-
molecular synthesis-dependent BAX translocation to the mito-
chondria (Putcha et al., 1999). During activation of the
intrinsic program of apoptosis, BAX translocates to mito-
chondria and forms large homo-oligomer complexes that per-
meabilize the outer mitochondrial membrane, allowing the
release of pro-apoptotic factors, such as cytochrome c (Youle
and Strasser, 2008). However, the signal transduction path-
ways and mechanisms that lead to the neuronal activity-
dependent BAX translocation to mitochondria are not yet
resolved. We hypothesized that proteins, such as NP1, that are
particularly expressed in neurons and whose expression is
induced by low neuronal activity might contribute to the tar-
geting of BAX to mitochondria.
Mitochondria are dynamic organelles that divide and fuse,
and it is the balance between these two complementary processes
that determines the morphology of the mitochondrial network;
in unhealthy cells, division (fission) becomes predominant and
the mitochondrial network fragments (Suen et al., 2008). Re-
cently, it has become evident that pro- and anti-apoptotic mem-
bers of the Bcl-2 family are involved in the regulation of the
mitochondrial network in both healthy and stressed cells (Autret
andMartin, 2009). BAX, for example, appears to have a different
physiological role in regulating mitochondrial dynamics in
healthy cells that is separate from its pro-apoptotic function
(Karbowski et al., 2006). A similar, but contrary, role has been
reported for anti-apoptotic members of the Bcl-2 family of pro-
teins, such as BCL-xL (Berman et al., 2009). Nonetheless, the
relationship between the apoptosis program and mitochondrial
dynamics is still subject to investigation.
In the present study, we have investigated the function of NP1
within the biochemical cascade of the apoptotic program evoked
by low neuronal activity as well as its role in mitochondrial dy-
namics. We found that NP1 is upstream of BAX in the apoptotic
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program of cell death activated by low neuronal activity and that
NP1 is preferentially located at mitochondria after K depriva-
tion. In addition, we show that NP1 colocalizes with BAX in the
mitochondria and that mitochondrial fragmentation induced by
low neuronal activity requires NP1 expression.
Materials andMethods
Cell culture. Primary cultures of CGNs were prepared from postnatal day
7 Sprague Dawley rat pups or from postnatal day 7 pups from heterozy-
gous B6.129X1-Baxtm1Sjk/J BAX knock-out mice (The Jackson Labora-
tory) of either sex as described previously (DeGregorio-Rocasolano et al.,
2001). Cells were dissociated in the presence of trypsin and DNaseI and
plated in poly-L-lysine (100 g/ml)-coated dishes at a density of 3 105
cells/cm2 for rat neurons and 2  105 cells/cm2 for mouse neurons in
basal Eagle’s medium supplemented with 10% heat-inactivated fetal bo-
vine serum, 0.1 mg/ml gentamicin, 2 mM L-glutamine, and 25 mM KCl.
Cytosine-D-arabinofuranoside (10M)was added to the culturemedium
18–20 h after plating to prevent replication of non-neuronal cells. Cells
were maintained at 37°C in a humidified incubator with 5% CO2 and
95% air. The cultures were left undisturbed until 7–8 d in vitro (DIV) for
the experiments. Formitochondrial transport experiments, primary cul-
tures of hippocampal neurons were obtained from E15–E17 OF1 mouse
embryo brains of either sex. Hippocampal neurons were seeded onto
poly-L-lysine-coated Fluorodish plates (World Precision Instruments)
and cultured as above. All procedures involving animals and their care
were approved by the ethics committee of the University of Barcelona,
and they were conducted in accordance with guidelines that conform
with national (Generalitat de Catalunya) and international laws and pol-
icies (Guide for the Care and Use of Laboratory Animals).
Genotyping of mice with different gene dosages of Bax. Tail DNA was
obtained following the protocol of The Jackson Laboratory. One milli-
meter of tail was cut and incubated at 55°C in a buffer containing 50 mM
KCl, 10mMTris-HCl, pH 8.3, 2.5mMMgCl26H2O, 0.45% (v/v)Nonidet
P-40, 0.45% (v/v) Tween 20, and 150 g/ml Proteinase K (Invitrogen).
After tissue digestion, the samples were incubated for 5 min at 95°C to
inactivate ProteinaseK, and 2l of this samplewas used for PCRanalysis.
Both thewild-type and themutantBax alleles were screened by PCR. The
wild-type allele was amplified with slightly modified primers using an
exon 5 forward primer (5-GAGCTGATCAGAACCATCATG-3) and
an intron 5 reverse primer (5-GGTTGACCAGAGT GCGTAGG-3),
which generated a fragment of 312 bp. The mutant allele was amplified
using a neo/pgk primer (5-CCGCTTCCATTGCTC AGCGG-3) and
the same intron 5 reverse primer. In this case, the size of the product
generated was 507 bp. Cycling parameters were as follows: an initial step
of 10 min at 95°C, 15 s at 95°C and 1 min at 60°C each for a total of 35
cycles, and after these, a final single step of 7 min at 72°C. PCR products
were analyzed on 2% agarose gels.
Induction of neuronal death by potassium deprivation. At 7–8 d after
plating, the medium in which the cells were grown was replaced with
either fresh serum-free medium supplemented with 25 mM potassium
(high K or K) or fresh serum-free medium containing 5 mM potas-
sium (low K or K).
Determination of cell viability and apoptosis in cultures. For studying
cell viability, we used two different approaches. In some experiments, cell
death was assessed using propidium iodide (PI) staining, which is ex-
cluded from viable cells. Damage to the plasma membrane permits the
entry of PI. Inside the cell, PI interacts with nuclear DNA and yields a
bright red fluorescence. This fluorescence wasmeasured in 24-well plates
using CytoFluor 2350 scanner (Millipore Corporation) with 530 nm
excitation (25 nm bandpass) and 645 nm emission (40 nm bandpass)
filters. The percentage of non-viable cells was measured as described
previously (Enguita et al., 2005). Baseline fluorescence (F1) was mea-
sured 1 h after the addition of 30 M PI showing the death not related to
the treatment. Several fluorescence readings were taken at different
times. Maximum fluorescence corresponding to 100% of cell death
(Fmax) was measured after incubation at 37°C for 10 min in the presence
of 500 M digitonin. The percentage of cell death was calculated follow-
ing this formula: %cell death 100 (Fn F1)/(Fmax F1), where Fn is
the fluorescence at any given time. In other experiments, cell viability was
analyzed by nuclei staining with Hoechst 33258 (Sigma) for morpholog-
ical determination of apoptosis. CGNs were washed with ice-cold PBS,
fixed with 4% paraformaldehyde in PBS containing 2% sucrose for 30
min at room temperature (RT), and subsequently incubated with ice-
coldmethanol for 2min. After some washes with ice-cold PBS, cells were
stained with Hoechst 33258 (175 ng/ml in PBS) for 10 min at RT, and
finally neurons were washed twice with PBS and covered with glycerol.
Nuclei were visualized using an Olympus IX70 inverted fluorescence
microscope with a 30 objective. In each experiment, photomicro-
graphs were taken from three randomly chosen fields per well by an
observer blinded to the treatments. At least threewells were examined for
each treatment.
Lentiviral vectors and constructs. The self-inactivating bicistronic len-
tiviral transfer vector constructs pWPI, pLVTHM, andpWPXL, aswell as
the second-generation lentivirus packaging and envelope plasmids, were
kindly provided by Dr. D. Trono (Lausanne, Switzerland). The map and
the sequences of these plasmids are available at Addgene (http://www.
addgene.org/). The constructs pWPI–NP1–GFP, for NP1 overexpres-
sion, pLVTHM–shRNAi–NP1–GFP, for the silencing of NP1, and
pLVTHM–shRandom–GFP, with a control non-target sequence, all of
them expressingGFP in a bicistronicmanner, were obtained as described
previously (Abad et al., 2006). The construct pWPXL–MtDsRed was
obtained by inserting within the restriction sites BamH1 and EcoR1 the
sequence of DsRed containing the mitochondrial targeting sequence of
cytochrome c oxidase complex IV (COX IV) at the N-terminal side. An
NP2–NP1 hybrid construct was obtained by substituting the first 240
bases of NP1 starting at the initiation codon with the corresponding
bases of neuronal pentraxin 2 (NP2). The DNA coding sequence bases
1–240 of NP2 and 241–1299 of NP1 were amplified by PCR. The result-
ing fragments were annealed and reamplified using NP2 3 forward and
NP1 5 reverse primers. The hybrid sequence was subcloned in the
pWPXL vector within BamH1 and EcoR1 restriction sites.
Viral particles pseudotyped with the vesicular stomatitis virus G gly-
coprotein were produced by transient transfection in HEK 293T cells
plated in 100 mm dishes in DMEM plus 10% FBS. When subconfluent,
HEK 293T cells were cotransfected with 20 g of lentiviral vector con-
taining the transgene, 15 g of the packaging plasmid psPAX2, and 6 g
of the envelope plasmid pMD2G using calcium phosphate. High-titer
stocks [1 107 transduction units (TU) permicroliter] were obtained by
ultracentrifugation and resuspension of the viral pellet in TNE buffer (in
mM: 50 Tris-HCl, pH 7.5, 130 NaCl, and 1 EDTA). Viral stocks were
stored at20°C and used within 1 month.
Transduction of CGNs with lentiviral vectors. CGNs were transduced
immediately after plating with 10  107 TU. This lentiviral titer was
found to produce no significant cell toxicity. A lentiviral vector carrying
a silencing cassette expressing an shRNA against no known target (sh-
Random–GFP) was used as control for knockdown experiments. An
empty pWPI lentiviral vector was used as control in transgene overex-
pression experiments. After addition of the lentivirus, cultures were
maintained at 37°C for 20 h, and then the medium was changed to fresh
BMEplus 10%FBS. The percentage of neurons expressingGFP 48 h after
transduction was 70–80%. In these cells, potassium deprivation experi-
ments were performed at DIV7–8.
Live imaging and quantification of axonal transport of mitochondria.
Hippocampal neurons were transfected with MtDsRed and either sh-
Random–GFP or shNP1–GFP and imaged 24–48 h later using a Leica
TCS SP2 confocal microscope equipped with a 63 oil-immersion ob-
jective. Cultures were maintained at 37°C using a heating insert on the
microscope stage and an incubating chamber, allowing circulation of a
controlled heated CO2 (5%)–air mixture for the control of pH. Formea-
surements of axonoplasmic transport of mitochondria, axonal processes
in transfected neurons were identified byGFP expression followingmor-
phological criteria, and directionality was determined for each axon.
Axonal mitochondria were registered with an additional digital zoom of
1.7. Time-lapse series of image stacks composed of five images (512
512 pixels) were taken every 6 s for 15min. All 151 images obtained were
processed primarily with Leica confocal software. Additional image pro-
cessing, analysis, and video compilation (at a frame rate of 10/s) and
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editing was performed with NIH ImageJ software (version 1.43K). Ky-
mographs were generated with MetaMorph Software (Molecular Devic-
es/MDS Analytical Technologies). In all cases, a mitochondrion was
considered motile when it moved 0.5 m during 1 min of recording.
Distances, speeds of retrograde, and anterograde transport were mea-
sured separately from the corresponding kymographs. To control for the
number of mitochondria analyzed, the average length was calculated for
each neuron and then the mean was calculated between axons.
SDS-PAGE and Western blot. Cells were solubilized in SDS sample
buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT,
and 0.01% bromophenol blue). After harvesting the cells, the extracts
were warmed at 85°C for 3 min and then briefly sonicated. The polypep-
tides were separated by SDS-PAGE. NP1 was assayed in either 10 or 12%
SDS-polyacrylamide gels. BAX, BIMEL, cleaved caspase-3, and cyto-
chrome c were analyzed in 15% gels. After electrophoresis, the samples
were electroblotted onto polyvinylidene difluoride (PVDF) membranes
(Millipore) according to the protocol of the manufacturer. Blots were
blocked with 5%nonfat drymilk (NFM) in Tris-buffered saline contain-
ing 0.1%Tween (TBS-T) before immunodetection. All primary antibod-
ies were prepared at the appropriate dilution in TBS-T solution
containing 3% bovine serum albumin (Sigma). The antibodies used in-
cluded the following: mouse monoclonal anti-rat NP1 (1:1000; BD Bio-
sciences), rabbit anti-cleaved caspase-3 (Asp 175) (1:750; Cell Signaling
Technology), mouse monoclonal anti-cytochrome c (1:1000; BD Biosci-
ences), rabbit anti-BAX (N-terminal) (1:1000; Millipore), and rabbit
anti-BIM (C34C5) (1:500; Cell Signaling Technology). A rabbit anti-
actin antibody (1:3000; Sigma)was used as a loading control for total and
cytosol-enriched fractions. To control for the amount of protein loaded
inmitochondria-enriched fractions, we used amonoclonal anti-COX IV
antibody (1:5000; Invitrogen). Peroxidase-conjugated goat anti-mouse
IgG (1:10,000; Jackson ImmunoResearch) or peroxidase-conjugated
goat anti-rabbit IgG (1:5000; Cell Signaling Technology) were the sec-
ondary antibodies used in a 5% NFM solution in TBS-T. Immunoreac-
tive proteins were visualized using an enhanced chemiluminescence
detection system (SuperSignal West Dura; Pierce), and the detection of
the bands was performed using a VersaDocModel 5000 Imaging System
quantifying their intensity with the Quantity One computer software
(Bio-Rad). The densitometry of the bands corresponding to total or
cytosolic NP1, cleaved caspase-3, or cytosolic BAXwas normalized to the
corresponding actin analysis. The values of cytochrome c, BAX, andNP1
bands in mitochondria-enriched fractions were normalized to the den-
sitometry of the corresponding COX IV band.
Measurement of cell-surface levels of NP1. CGNs were biotinylated us-
ing the Cell Surface Protein Isolation kit (Pierce) following the protocol
of the manufacturer. Cells were washed twice with cold PBS and incu-
bated at 4°C with biotinylation reagent (0.25 mg/ml sulfo-NHS-SS-Bio-
tin; Pierce) for 30 min with gentle agitation. The biotinylation reaction
was stopped by addition of cold quenching solution (Pierce). Cells were
lysed, and solubilized proteins were incubated for 1 h at RT with Immo-
bilizedNeutrAvidinTMGel slurry (Pierce). The bound biotinylated pro-
teins were eluted by incubating for 1 h at RTwith SDS-PAGEbuffer (62.5
mMTris-HCl, pH 6.8, 1% SDS, 10% glycerol, and 50mMDTT), followed
by centrifugation for 2 min at 1000  g. Biotinylated proteins were
resolved by 8% SDS-PAGE and transferred to PVDFmembranes (Milli-
pore). We used actin as a loading control for total protein extract and as
a standard control to ensure that there was no biotinylation of intracel-
lular proteins. The labeling of proteins was visualized by ECL and quan-
tified as described above. The proportion of NP1 at the cell surface was
determined bymeasuring the band densities of biotinylated NP1 and the
NP1 in the total lysate.
Subcellular fractionation. Subcellular fractionation was performed in
cultured rat CGNs plated in six-well plates. In the experiments investi-
gating gain or loss of NP1 function, cells were transduced with the lenti-
viral vector for transgene overexpression of NP1 (pWPI–NP1) or with
the vector for NP1 silencing (shNP1) at DIV0. Treatment with low K
was performed when cells were mature at DIV7–8. At different times
after treatment with low K, cells were harvested, and mitochondria-
enriched fractions were obtained using the Mitochondrial Isolation Kit
for Cultured Cells from Pierce Thermo Scientific following the instruc-
tions of the manufacturer. Mitochondria-enriched pellets were solubi-
lized in SDS sample buffer and warmed 3 min at 85°C. Fractions were
analyzed for cytochrome c, BAX, and NP1 by Western blot as described
above.
Immunocytochemistry. CGNs were plated at a density of 2 105 cells/
cm2 on chamber slides (LabTek, VWR) or glass coverslips coated with
poly-L-lysine (100 g/ml). After plating, the cells were transduced with
pWPXL–MtDsRed and the corresponding lentiviral vectors as described
above. Cells were treated with high or low K at DIV7–8. After 4–8 h,
the medium was removed, and the cells were rinsed in PBS and fixed in
4% paraformaldehyde in PBS containing 2% sucrose at 4°C for 10 min.
After 5 min incubation with 0.1 M glycine/PBS, cells were permeabilized
in 0.5% CHAPS/PBS for 30 min before washing briefly in PBS. Blocking
was performed in 5% NGS/PBS for 30 min at RT. Incubation with pri-
mary antibodies, diluted in 1% NGS/PBS, was performed either over-
night at 4°C or for 3 h at RT. Primary antibodies used were mouse
anti-NP1 (1:50; BD Biosciences), rabbit anti-NP1 (1:100; BD Biosci-
ences), and/ormouse anti-BAX clone 6A7 (1:100; BD Biosciences). After
incubation, cells were washed in 1% NGS/PBS and incubated in sec-
ondary antibodies, Alexa Fluor-488 anti-mouse/rabbit or Alexa
Fluor-633 anti-mouse (Invitrogen) at 1:1000 for 1 h at RT. After PBS
washes, cells were coverslipped using Prolong Gold Antifade (Invit-
rogen). In some cases, CGNs were coverslipped after fixing without
performing immunocytochemistry for the analysis of mitochondria
marked with MtDsRed.
Imaging and analysis. Images were acquired using a 63 oil-
immersion objective (numerical aperture 1.4) on a Leica TCS SPE con-
focal microscope. Each channel was scanned separately using identical
settings for laser power and photomultiplier gain/offset within each ex-
periment. No crosstalk or bleed-through between different channels oc-
curred, and no appreciable signal was visible in secondary antibody
controls. For determining the percentage of active BAX-positive cells,
single-slice images were taken. For imaging of the mitochondrial net-
work (asmarked byMtDsRed), stacks were taken using 0.5mor system
optimized step sizes. Maximum projections were obtained using NIH
ImageJ, and mitochondrial length was determined by selecting neuritic
regions and analyzing the lengths of thresholdedmitochondria using the
NIH ImageJ “Analyze Particles” module. In a similar manner, the areas
occupied by NP1 andmitochondria were quantified to show the effect of
deprivation on NP1 levels at neuritic mitochondria. The length of neu-
ronal processes was measured using NIH ImageJ software. Neuritic mi-
tochondrial mass was calculated bymultiplying the meanmitochondrial
length by the number of mitochondria divided by neurite length. Vol-
ume rendering of NP1 and MtDsRed was performed using the VolumeJ
plug-in for NIH ImageJ. For orthogonal sectioning, stacks were obtained
using the optimal step size as determined by the Leica confocal software.
Line plot analysis was performed (using the MtDsRed signal as a guide)
in single optical slices with the Profile Plot function of NIH ImageJ.
Image adjustment was performed after analysis for display purposes
only.
Immunoprecipitation. BAX immunoprecipitation was performed in
protein extracts from either total brain or CGNs treated with low K to
assess the interaction of native proteins or from HEK 293T cells trans-
fected with recombinant rat NP1 and BAX cDNAs. For total rat brain
extraction, the whole rat brain was Dounce homogenized in 10 vol of
immunoprecipitation buffer (inmM: 50 Tris-HCl, pH 7.5, 100NaCl, and
2 CaCl2) containing 1% Triton X-100 and mini-EDTA Free protease
inhibitor cocktail (Roche). The lysate was centrifuged at 1000  g for 5
min, and the supernatant was incubated 1 h at 4°C and centrifuged at
50,000  g for 15 min. CGNs were potassium deprived for 2 h on
DIV7–8, washed twice with PBS on ice, and lysed in immunoprecipita-
tion buffer (as for total brain). The lysate was incubated for 20min on ice
and centrifuged at 4°C at 10,000  g for 10 min to remove insoluble
components. HEK 293T cells were transfected using a standard calcium
phosphate transfection protocol. At 24 h after transfection, the cells were
washed twice with PBS on ice and lysed in immunoprecipitation buffer
containing 1% Triton X-100 and mini-EDTA Free protease inhibitor
cocktail (Roche); supernatants were obtained as for CGNs. The immu-
noprecipitation of the supernatants—total brain, CGNs, and HEK
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293Ts—was performed using Protein A Magnetic Beads (New England
Biolabs) following the instructions of the manufacturer. Briefly, the ly-
sate was incubated for 20 min at RT with the magnetic beads previously
bound to 4 g of the rabbit anti-BaxNT antibody (Millipore). For the
control immunoprecipitations, we used 4 g of ChromePure rabbit IgG
whole molecule (Jackson ImmunoResearch). After immunoprecipita-
tion, the beads were washed three times with PBS, eluted in SDS sample
buffer for 5 min at 85°C, and subjected to Western blotting with the
corresponding antibodies.
Statistical analyses. The results are expressed as the mean  SEM.
Unless otherwise specified, the n value refers to the number of indepen-
dent cell cultures. The statistical significance of the differences was ex-
amined using independent t tests or one-way ANOVAwith Bonferroni’s
post hocmultiple comparisons tests when required.
Results
Treatment of CGNs with low K increases the amount of NP1
in mitochondria
We have shown previously that NP1 overexpression precedes
cell death induced by K deprivation in cultured CGNs and
that this increase in NP1 expression contributes to apoptosis
(DeGregorio-Rocasolano et al., 2001; Enguita et al., 2005). To
investigate the mechanisms of this pro-apoptotic effect, we
analyzed the subcellular localization of NP1 after induction of
the apoptotic program by low K. First, we biotinylated the
proteins located at the neuronal surface to determine the
amount of NP1 tethered to the neuronal membrane with ex-
posed residues at the extracellular space. The results showed that
the amount of NP1 at the neuronal surface in control CGNs is a
small fraction (5  1%) of the total cellular NP1 (Fig. 1A). In
agreement with previous results, treatment with lowK caused a
marked increase (310  26%) in total NP1 but did not signifi-
cantly modify the amount of NP1 at the cytoplasmic membrane
surface (8 2%), indicating that the amount of NP1 evoked by
low K was either released or targeted to other locations (Fig.
1A). Because we could not detect secreted NP1 in the culture
medium either before or after K deprivation (data not shown),
we next performed biochemical experiments with subcellular
fractions to determine the subcellular distribution of the NP1
evoked by low K. NP1 was not detected in nuclear fractions
(results not shown). In contrast, as shown in Figure 1B, treat-
ment of CGNs with low K caused a significant increase in pro-
tein levels of NP1 in mitochondria-enriched fractions (282 
45%)when comparedwith highK control cells. In comparison,
low K caused a small increase in NP1 in cytosolic fractions
(180 24%), but this effect did not reach statistical significance
(Fig. 1B). These results suggest that the NP1 induced after acti-
vation of the apoptotic program by low K is located predomi-
nantly at mitochondria.
To substantiate further the subcellular localization of NP1, we
performed immunocytochemical studies in CGNs that were
transduced with MtDsRed, a red fluorescent protein targeted to
mitochondria. Confocal images of MtDsRed and NP1 immuno-
fluorescence showed that treatment with low K caused a
marked increase in NP1 immunofluorescence in mitochondrial
regions (Fig. 1C,D). Subsequent quantitative analyses of line pro-
file plots performed on images of equivalent MtDsRed fluores-
cence between treated and control cells confirmed that treatment
of CGNs with low K caused a significant increase in NP1 im-
munofluorescence inmitochondria (314 31%over that in high
K controls) (Fig. 1E). Together, these findings confirm the re-
sults observed in the biochemical subcellular fractionation stud-
ies and indicate that the NP1 synthesized after activation of the
apoptotic program by low K is predominantly targeted to
mitochondria.
To explore further the targeting of NP1 to mitochondria, we
examined the influence of the N-terminal side of NP1, which
contains a putative mitochondrial targeting sequence, on its sub-
cellular distribution. We expressed in HEK 293T cells, an NP2–
NP1 hybrid protein in which the first 80 amino acids of the NP1
N terminus were substituted with the corresponding amino acids
of NP2, another protein of the same family that contains a func-
tional signal peptide (Tsui et al., 1996). The subcellular distribu-
tion of the hybrid NP2–NP1 protein was significantly different
from that of NP1. Compared withNP1, the amount of the hybrid
NP2–NP1 was lower (50  5%) in the mitochondrial enriched
fraction and higher (278  31%) in the cytosolic fraction, indi-
cating that the first 80 amino acids of NP1 N-terminal side con-
tribute to its mitochondrial localization (results not shown).
Low K induces mitochondrial fragmentation associated
with NP1 at neuritic mitochondria
Because disruption of themitochondrial network has been linked
to the apoptotic cascade, we decided to study the role of NP1 in
mitochondrial fragmentation. Reduction of extracellular K sig-
nificantly decreased mean neuritic mitochondrial length by
33% (from 2.1 0.1 m in controls to 1.4 0.2 m after 6 h
of treatment with low K) (Fig. 2A,B). Although analyses of
mitochondrial length were performed specifically in the neurites,
fragmented mitochondria were evident in the soma as well (Fig.
2B). In agreement with previous work (Loucks et al., 2009), frag-
mentation was detectable after 6 and 8 h of K deprivation but
not at 4 h, whereas mitochondrial length in control cultures
maintained in high Kwas not significantly altered over the time
course (Fig. 2A). Next, we performed confocal imaging experi-
ments on CGNs that had been K deprived for 4, 6, and 8 h (Fig.
2C,D) andmeasured the amount ofNP1puncta colocalizingwith
mitochondria located in neurites. To account for differences
in mitochondrial area, we expressed this value as the percent-
age of MtDsRed signal. Although NP1 puncta were also clearly
visible in control neurites, a small but significant increase in
NP1 protein in neurites near mitochondria was evident by 4 h
of K deprivation (from 10  1% in controls to 17  3% in
low K). The associations were increased further and reached a
maximum after 6 of K deprivation (to 26  3%) (Fig. 2C).
Furthermore, using higher-resolution confocal imaging, NP1
puncta could be found at mitochondrial tips and putative scis-
sion sites, at times encircling thinner regions within thicker mi-
tochondria (Fig. 2E, arrows).
NP1 is required for mitochondrial fragmentation in
K-deprived CGNs
Because of the close physical and temporal association between
NP1 and fragmented mitochondria, we next studied what effect
knockdown of NP1 has on low K-induced mitochondrial frag-
mentation. NP1 knockdown was performed using RNAi via
transduction of the silencing vector pLVTHM–shRNAi–NP1
(shNP1). As shown in Figure 3A, transduction of CGNs with
shNP1 reduced basal NP1 protein levels and completely blocked
the increase in NP1 induced by low K. Thus, low K increased
NP1 levels to 299 51%of high K controls; this was reduced to
91  21% of control in low K-treated cells transduced with
shNP1. Moreover, treatment with low K for 6–8 h caused a
significant 30% reduction in mitochondrial length (from 1.9 
0.1m in control to 1.3 0.1m in lowK-treatedCGNs) (Fig.
3C), confirming the time-course studies of the effect of potas-
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siumdeprivation onmitochondrial length reported previously
in Figure 2A. Notably, knockdown of NP1 resulted in a clear
blockage of low K-induced mitochondrial fragmentation
(Fig. 3C). In addition, NP1 knockdown blocked cell death
induced by low K (Fig. 3B). Thus, low K increased cell
death from 17  4% (high K) to 69  11%, whereas shNP1
transduction reduced cell death induced by low K to 26 3%.
Furthermore, NP1 overexpression potentiated low K-evoked
cell death (see Fig. 6A). These results indicate that NP1 is re-
quired for mitochondrial fragmentation in response to reduced
activity and suggest that NP1 regulates mitochondrial dynamics
in addition to apoptosis.
NP1 is involved in mitochondrial trafficking
Mitochondrial dynamics and trafficking are essential to supply
appropriate energy to distal neuronal branches and for correct
neurotransmission and neuronal viability. Thus, given that NP1
is required formitochondrial fragmentation evoked by low activ-
ity, we investigated whether NP1 is also involved in mitochon-
drial trafficking.Weused hippocampal cultured neurons because
Figure 1. NP1 is preferentially located in mitochondria after low K. A, Quantitative analysis of surface and total NP1 after low K treatment. At DIV7, CGNs cultures were treated with K
deprivation for 6 h. Then neurons were biotinylated for 30 min at 4°C to label surface proteins and NP1 levels were analyzed byWestern blot and densitometric analysis. Total NP1 was normalized
to the levels of actin. Amarked increase in total, but no significant differences in the levels of surface, NP1was foundbetweenK andK treatments. Values aremean SEM. The ratio of NP1over
actinwas expressed as percentage of K values. *p	 0.01, significantly different from corresponding high K control (two-tailed independent t test, n 3).B, Quantification and representative
Western blot of subcellular distribution of NP1 after 8 h of treatment with low K. The densitometric values of NP1 bands in cytosol or mitochondria-enriched fractions were normalized to the
corresponding actin or COX IV bands, respectively. Values are mean SEM. *p	 0.001, significantly different from corresponding high K; #p	 0.05, significantly different from low K
cytosol-enriched fraction (repeated-measures ANOVA with Bonferroni’s multiple comparison test, n 6). C, Representative confocal images of mitochondria labeled with MtDsRed (red) and
immunocytochemistry of NP1 (green) after 6 h of low K treatment. The negative control for NP1 immunofluorescence was performed by omitting NP1 primary antibody in cells treated with low
K, whenNP1 levels are high and there ismitochondrial fragmentation. LowK treatment increasedNP1 immunofluorescence inmitochondrial regions. Scale bar, 5m.D, Highermagnification
of areasmarkedwith awhite rectangle in C and corresponding line profile plots showing increased localization of NP1 inmitochondria after treatmentwith lowK. Scale bar, 5m. E, Quantitative
analyses of line profile plots of images with equivalent MtDsRed immunofluorescence. *p	 0.001, significantly different from corresponding high K control (two-tailed independent t test, n
17 neurons).
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they exhibit longer processes in which
mitochondria can be readily identified
and traced by live imaging. Neurons
were transfected at DIV4 with MtDsRed
and pLVTHM vectors expressing control,
scrambled, or shNP1 sequences and mi-
tochondrial motility was evaluated with
live-imaging techniques. At 2–3 d after
transfection,axonswere identifiedmorpho-
logically and imaged over 15 min periods.
Control neurons exhibited high rates of
mitochondrial motility, which were trans-
ported in both the anterograde and retro-
grade directions (Fig. 4A). Only a fraction
of mitochondria (30%) (Fig. 4B)
moved over the 15min recording periods,
in agreement with previous studies (Ma-
caskill et al., 2009). Examination of the
series of images suggested that mitochon-
drial transport increased after knockdown
of NP1. To substantiate further this no-
tion, images were represented as kymo-
graphs (Miller and Sheetz, 2004), and
mitochondrial motility was analyzed
quantitatively (Fig. 4B). Comparison of
mitochondrial motility in control and
shNP1-transfected neurons revealed that
knockdown of NP1 results in a significant
increase in the percentage of moving mi-
tochondria. Additional analysis of this ef-
fect showed that knockdown of NP1
increases the percentage of anterograde
moving mitochondria without signifi-
cantly altering the number of retrograde
moving mitochondria. However, knock-
down of NP1 did not have a significant
effect on either anterograde or retrograde
mitochondrial transport velocity (Fig.
4C). Together, these experiments indicate
that NP1, in addition to regulating mito-
chondrial dynamics during apoptosis,
also regulates mitochondrial motility and
transport in healthy living neurons.
Pro-apoptotic effect of NP1 depends on
the presence of BAX
To gain additional insight into the mecha-
nism of the mitochondrial effects of NP1,
we next measured neuronal death evoked by
lowK in culturedmatureCGNs fromwild-
type (Bax/), heterozygous (Bax/), and
homozygous Bax-deficient (Bax/) mice
(Fig. 5A). In agreement with previous studies
(Miller et al., 1997), exposure to reduced ex-
tracellular K caused significant death in
CGNs from both wild-type and heterozy-
gous Bax/mice but not in Bax/mice. The lack of effect of low
K in cultures ofBax/micewas sustained for up to 72 h, indicat-
ing that any of the cell death pathways activated by reduction of
neuronal activity requires the presence of BAX to proceed with the
execution phase of the apoptotic program (Fig. 5A).
To ascertain the place of NP1 overexpression within the se-
quence of events of the apoptotic program induced by the reduc-
tion of neuronal activity, we studied the effect of low K on NP1
expression in neurons from Bax-deficient mice. Treatment with
low K increased NP1 levels similarly in cultured CGNs from
mice with different gene dosages of Bax (Fig. 5B), indicating that
NP1 overexpression evoked by low K does not depend on the
presence of BAX and that the function of NP1 is upstream or in
parallel with BAX function.Wenext transducedCGNs fromBax-
Figure 2. Low K induces mitochondrial fragmentation in CGNs in culture with a concomitant increase in mitochondrially
associated NP1. Rat CGNs were transduced with MtDsRed and treated with low K for various times before fixation and analysis.
A, Measurement of mitochondrial length in response to low extracellular K. Treatment with low K resulted in a significant
decrease in mitochondrial length after 6 and 8 h, but not 4 h, of deprivation. Values are mean SEM. *p	 0.001, significantly
different from high K control cultures (two-tailed independent t test, n 3 independent cultures, 250–300 mitochondria at
each time/treatment period). B, Representative images showing the mitochondrial network in control and deprived cells. Scale
bar, 20m. C, NP1 levels at neuriticmitochondria after low K treatment. Analysis was performed by expressing the area of NP1
at mitochondria in neurites as a percentage of the area occupied bymitochondria (MtDsRed). An increase in NP1 levels relative to
MtDsRed was visible after 4, 6, and 8 h. Values are mean SEM. *p	 0.01, **p	 0.001, significantly different from high K
control cultures (two-tailed independent t test,n4 independent cultures, 100–200neurites at each time/treatment period).D,
Representative images showing NP1 at neuritic mitochondria over time. Scale bar, 2m. E, Representative images showing NP1
in deprived CGNs in culture. Volume-rendered images showing the localization of NP1 at mitochondrial locations, including
putative mitochondrial scission sites (see arrow and inset). Scale bar, 2m.
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deficient mice with a lentiviral vector for transgene overexpres-
sion of NP1 (pWPI–NP1). In neurons fromwild-type mice, NP1
overexpression significantly increased the number of apoptotic
nuclei compared with cells transduced with the control vector
pWPI–Ctrl (from 15 2% to 31 3%) (Fig. 5C). NP1 caused a
similar increase in apoptotic nuclei in neurons fromBax/mice
(from 25 5 to 45 9%). In contrast, transgene overexpression
of NP1 in Bax/mice did not modify the number of apoptotic
nuclei comparedwith control transduced cells (from7 1 to 8
1%) (Fig. 5C). These results indicate that NP1 needs BAX to
induce cell death and confirm thatNP1 is upstreamof BAX in the
apoptotic program.
NP1 causes apoptosis by activating mechanisms of the
intrinsic program of cell death downstream of BAX
Following from the observation that transgene overexpression of
NP1 is sufficient to induce apoptosis, we next investigated the
influence of exogenous NP1 on neuronal death evoked by K
deprivation in rat CGNs. Consistent with the results obtained in
CGNs from wild-type and heterozygous Bax mice (Fig. 5C),
transgene overexpression of NP1 caused a significant increase in
the number of apoptotic nuclei (from 13  3% in high K/
pWPI–Ctrl to 30  4% in high K/pWPI–NP1) in control un-
treated neurons (Fig. 6A). Moreover, NP1 significantly
potentiated the increase in the number of apoptotic nuclei caused
by low K (83 2% of apoptotic nuclei in low K/pWPI–NP1-
transduced cells compared with 68  2% of apoptotic nuclei in
low K/pWPI–Ctrl-transduced neurons) (Fig. 6A).
Next, we investigated whether NP1 activates mechanisms of
the apoptotic program that are downstream of BAX. It is well
known that activation of BAX induces cytochrome c release to the
cytosol and caspase-3 cleavage (Galluzzi et al., 2009). First, we
studied the effects of NP1 on cytochrome c release by measuring
the amount of cytochrome c in mitochondria-enriched subcellu-
lar fractions. Treatment of CGNs with low K for 8 h decreased
the amount of cytochrome c in mitochondria-enriched fractions
to 53 5% of control values (Fig. 6B). Likewise, overexpression
of NP1 significantly reduced (to 71 10% of control values) the
amount of cytochrome c inmitochondria comparedwith control
high K-treated cultures. This effect of NP1 was not significantly
different from that observed after treatment with low K. In
addition, NP1 overexpressionmarkedly potentiated the low K-
evoked decrease in the amount of mitochondrial cytochrome c
(to 19 4% of control values) (Fig. 6B).
Subsequently, we studied the effect of NP1 on the cleavage of
caspase-3. Western blot analysis showed that NP1 significantly
potentiates the amount of cleaved caspase-3 evoked by low K
(Fig. 6C). This effect of NP1was observed between 6 and 8 h after
low K treatment and was significantly attenuated by reducing
NP1 protein levels via the simultaneous transduction of the si-
lencing vector pLVTHM–shRNAi–NP1 (shNP1). NP1 caused
small increases in the levels of cleaved caspase-3 in control cul-
tures in some experiments, but this effect did not reach statistical
significance, probably because of the relatively small magnitude
of the effect and the variability of the Western blot detection
procedure. Altogether, these results indicate that NP1 overex-
pression is sufficient to activate mechanisms of the apoptotic
program that are downstream of the activation of BAX, although
NP1 requires the presence of other pro-apoptotic proteins of the
intrinsic program to induce a complete apoptotic effect equiva-
lent to that observed after treatment with low K.
NP1 overexpression increases the number of cells with
active BAX
Because we found that the localization of NP1 in mitochondria
evoked by lowK is associatedwith a reduction inmitochondrial
cytochrome c and regulates activation of caspase-3 (Fig. 6), two
Figure 3. NP1 is required for apoptosis andmitochondrial fragmentation. CGNswere transduced
with pLVTHM–shNP1 (shNP1) to knockdown NP1 or with a pLVTHM–shRandom expressing an
shRNAagainst no known target (shRandom) and treatedwith lowK for 6–8h.A, Representative
Westernblot andquantificationofNP1 levels after lowK. NP1wasnormalized to the levels of actin
andanalyzedbydensitometricanalysis.Values,expressedaspercentageofcontrol,aremeanSEM.
*p	0.01, significantlydifferent fromhighK/shRandom(one-wayANOVAwithBonferroni’smul-
tiple comparison test, n 6). B, Quantification of apoptosis in cultures treated with low K. Cell
death was assessed using PI staining after 24 h in low K. Values are mean SEM. *p	 0.001,
significantly different from high K/shRandom (one-way ANOVA with Bonferroni’s multiple com-
parison test, n 6). C, Quantification of the effect of NP1 knockdown onmitochondrial lengthwith
andwithout lowK. For theseexperiments, CGNswere transducedwithMtDsRedandeither shRan-
domor shNP1andonDIV7–8were treatedwith lowK for 6–8h. Treatmentwith lowK signif-
icantly decreased mitochondrial length in cells transduced with the control vector but not in those
transduced with shNP1. Values are mean SEM. *p	 0.001, significantly different from high
K/shRandom; &p	 0.001, significantly different from low K/shRandom (two-tailed indepen-
dent t test,n 2 independent cultures, 250–400mitochondria at each treatment).
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processes that require BAX oligomerization, we next studied the
influence of NP1 on BAX activation. When active, BAX under-
goes a conformational change in the N terminus that exposes an
epitope comprising amino acids 13–19 known as 6A7 (Hsu and
Youle, 1998). Using an antibody that recognizes the 6A7 epitope
to distinguish active BAX from the other non-active forms, we
found that NP1 overexpression significantly increases the num-
ber of cells with active BAX (7 1% in cells transduced withNP1
comparedwith 4 1% in controls) (Fig. 7A,B). In addition,NP1
significantly potentiates the increase in the number of active
BAX-expressing cells after 4 h of treatment with low K (17 
2% in cells transduced with NP1 and treated with low K com-
pared with 11 1% in the respective controls). At the same time,
the silencing of NP1 by shRNAi significantly reduced the effect of
low K on active BAX (7  1% in cells transduced with shNP1
and treated with low K compared with 11 1% in the respec-
tive controls), indicating that NP1 is required for the increase in
active BAX evoked by low K (Fig. 7A,B).
NP1 regulates the accumulation of BAX in mitochondria
TodeterminewhetherNP1 is also involved in the translocation of
BAX from cytosol to mitochondria, we studied the effect of NP1
on the accumulation of BAX in mitochondria and on the subcel-
lular redistribution of BAX induced by low K. In agreement with
previous studies (Miller et al., 1997), treatment of CGNs with low
K did not significantlymodify the amount of total BAXmeasured
by Western blot when compared with untreated cells (results not
shown). Furthermore, consistentwithprevious results (McGinnis et
al., 1999), biochemical experiments measuring the amount of total
BAX in subcellular fractions showed that treatment of CGNs with
low K increases the amount of BAX in mitochondria after 2 h of
treatment (137 12% control) (Fig. 7D) but not after 1 h of treat-
Figure 4. Knockdown of NP1 increases anterograde mitochondrial trafficking. Axonal mitochondrial trafficking was measured in live hippocampal neurons transfected with MtDsRed and
shRandom–GFP or shNP1–GFP and recorded 48 h afterward using a Leica TCS SP2 confocal microscope with a 63 oil-immersion objective. A, The white rectangle in the top panel identifies the
section of the imaged axon shown in the image series below froma transfected neuron expressing GFP from shRandomor shNP1 bicistronic vectors. The bottompanels showa series of four confocal
images taken every 30 s showingmitochondrialmotility in live axons overexpressingMtDsRedand shRandomor shNP1. Colored arrows identify the samemitochondria through thedifferent frames.
B, Representative kymograph of the full acquisition period (15 min of movie). Kymographs are arranged with the distal axonal end on the right. C, Graphs showing quantitative analyses of the
percentage age ofmotilemitochondria and themitochondrial velocity asmeasured in the kymographs. Values aremean SEM. *p	 0.05, **p	 0.01, significantly different from corresponding
shRandom control (independent t test, two tailed, n 40–50 axons in each condition). Scale bar, 10m.
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Figure 5. Apoptotic effects of NP1 depend on BAX. Granule cell cultures from wild-type (Bax/),
heterozygote (Bax/), and homozygote Bax-deficient (Bax/) mice were treated with low K
(K) orwith control highK (K) atDIV8.A, Cell deathwasmeasuredbyPI staining. Kdepriva-
tion increased cell death inBax/ andBax/butnot inBax/mice. Values aremeanSEM.
*p	0.01, significantly different from the correspondinghighK (one-wayANOVAwithBonferro-
ni’smultiple comparison test, n 3 independent experiments).B, Quantitative analysis and repre-
sentative Western blot of NP1 protein expression after 6 h of low K treatment in the three Bax
genotypes. Reduction of extracellular K concentration increases NP1 expression in all three geno-
types. NP1was normalized to the levels of actin. The intensity of the bandswas determined by den-
sitometricanalysis. The rateofNP1overactin isexpressedaspercentageof control values.*p	0.01,
significantly different from corresponding high K control (one-wayANOVAwith Bonferroni’smul-
tiple comparison test, n 5 independent experiments). C, Granule cells were transduced with the
bicistronic lentiviral vector for transgene expression of NP1 (pWPI–NP1) or with the control vector
expressingGFP(pWPI–Ctrl).ApoptoticnucleiwereassessedwithHoechst33258staining.NP1trans-
duction increases the number of apoptotic nuclei in Bax/ and Bax/mice but not in Bax/
animals.ValuesaremeanSEMofn6independentexperiments.Thenumberofanimalsandcells
countedwere as follows:Bax/,n8mice (pWPI–Ctrl,n2351 cells; pWPI–NP1,n2971 cells),
Bax/, n 3 mice (pWPI–Ctrl, n 1380 cells; pWPI–NP1, n 1606 cells), Bax/, n 6 mice
(pWPI–Ctrl,n4093cells;pWPI–NP1,n4200cells).*p	0.01,significantlydifferentfromcorrespond-
ingpWPI–Ctrl (one-wayANOVAwithBonferroni’smultiplecomparisontests).
Figure 6. NP1 activates mechanisms of the intrinsic program of apoptosis. Rat CGNs were
transduced with control lentiviral vector (pWPI–Ctrl) or with lentiviral vector for transgene
expression of NP1 (pWPI–NP1) and treated with low K. A, Apoptotic nuclei were measured
after 24 h in lowK byHoechst 33258 staining. Values aremean SEM. &p	 0.05 and *p	
0.001, significantly different from K/pWPI-Ctrl; #p	 0.05, significantly different from K/
pWPI–Ctrl (one-way ANOVAwith Bonferroni’smultiple comparison tests, n 3).B, Represen-
tativeWestern blot and quantification ofmitochondrial cytochrome c over COX IV after low K
treatment. Lentivirus transduced neurons were treated with low K for 8 h; mitochondria-
enriched fractions were obtained, and cytochrome cwas quantified by densitometric analysis.
Transgene expression of NP1 induces cytochrome c release frommitochondria and also poten-
tiates the release evoked by low K treatment. *p	 0.001, significantly different from high
K/pWPI–Ctrl; &p	 0.01, significantly different from high K/pWPI–Ctrl; #p	 0.01, sig-
nificantly different from low K/pWPI–Ctrl (one-way ANOVAwith Bonferroni’s multiple com-
parison test, n 8). C, Representative Western blot and densitometric analysis of cleaved
caspase-3 over actin after 6–8 h of low K treatment at DIV7. Caspase-3 was assayed with
rabbit anti-cleaved caspase-3 (Asp 175) that recognizes only the cleaved form. NP1 potentiates
the increase of cleaved caspase-3 evoked by low K, and this effect is blocked by NP1 knock-
down. Values are mean SEM. *p	 0.01, significantly different from high K pWPI–Ctrl/
shRandom; &p	 0.001, significantly different from high K/pWPI–NP1/shRandom; #p	
0.05, significantly different from low K/pWPI–Ctrl/shRandom (one-way ANOVA with Bon-
ferroni’s multiple comparison test, n 5).
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ment (Fig. 7C). Overexpression of NP1 sig-
nificantly increased the amount of BAX in
mitochondria-enriched subcellular frac-
tions in control high K-treated cells
(128 5% of control values) and potenti-
ated the accumulationofBAX inmitochon-
dria after 1 h of treatment with low K
(155  5% of control values) (Fig. 7C).
Moreover, knockdown of NP1 blocked the
accumulation of BAX in mitochondria-
enriched fractions observed after 2 h of
treatment with low K (Fig. 7D) and pre-
vented thedecrease in cytosolicBAXevoked
by 8 h of treatment with low K (Fig. 7E).
These results indicate that NP1 facilitates
and is required for the translocation of BAX
tomitochondria.
NP1 cooperates with BAX in the
regulation of mitochondrial length and
mass by neuronal activity
Because we found previously that knock-
down of NP1 prevents mitochondrial
fragmentation evoked by lowK and that
NP1 facilitates the translocation of BAX to
mitochondria, we asked whether NP1 in-
fluences mitochondrial morphology in
CGNs from Bax knock-out mice. Con-
firming the previous results reported in
rat CGNs (Fig. 3C), low K significantly
reduced by 40% mitochondrial length
in wild-type Bax mice (1.7  0.1 and
0.96  0.03 m in control and low K-
treated wild-type CGNs, respectively)
(Fig. 8A). This effect was blocked by
cotransduction of the silencing vector for
NP1 (Fig. 8A,C). In addition, in un-
treated CGNs from Bax knock-out mice,
mitochondrial length was significantly
decreased by 30% compared with that
in untreated wild-type CGNs (1.7  0.1
and 1.2 0.04m in CGNs from Bax/
and Bax/, respectively) (Fig. 8A,C).
This is consistent with a role for BAX in
promoting fusion under basal conditions,
which, although shown previously in a
number of cell lines and mouse cortical
neurons (Karbowski et al., 2006; Cleland
et al., 2011), had not been studied previ-
ously in CGNs. Furthermore, in CGNs
from Bax knock-out mice, reduction of
extracellular K, despite causing a
marked increase in NP1 levels (Fig. 5B),
did not induce an additional decrease in
mitochondrial length (Fig. 8A), implying
that NP1 requires BAX to induce mito-
chondrial fragmentation under apoptotic
conditions. Moreover, knockdown of
NP1 in the absence of BAX had no signif-
icant effect on mitochondrial length in
CGNs maintained in high K (Fig. 8A),
further confirming that the prevention of
mitochondrial fragmentation observed
Figure 7. NP1 increases the number of cells with active BAX and contributes to BAX accumulation in mitochondria. CGNs were
transduced with control lentiviral vector (pWPI–Ctrl/shRandom) or with the lentiviral vectors for transgene expression of NP1
(pWPI–NP1) or for NP1 knockdown (shNP1) at DIV0. At DIV7, the cells were treated with high or low K before performing
immunocytochemistry or subcellular fractionation. A, Representative immunofluorescence confocal images of active BAX and
DAPI. Active BAX is shown in red, and cell soma (DAPI) are shown in blue. Scale bar, 20m. B, Quantitative analysis of the effect
of NP1 and of 4 h of treatment with low K on the percentage of cells with active BAX. *p	 0.001, significantly different from
K/shRandom; &p	 0.05, &&p	 0.001, significantly different from corresponding lentiviral control; #p	 0.05, ##p	 0.001,
significantly different from K/shRandom (two-tailed independent t test, n  3 independent cultures,). C, D, Quantitative
analyses and representative Western blots of the effects of NP1 overexpression and knockdown on the accumulation of BAX in
mitochondria-enriched subcellular fractions. Samples of mitochondria-enriched fractions for detection of BAX by Western blot
were obtained 1 h (C) or 2 h (D) after treatment with low K. The densitometric analysis of BAX was normalized to the corre-
sponding COX IV bands. Values are mean SEM. *p	 0.05, significantly different from the respective control. #p	 0.05,
significantly different from high K/ pWPI–NP1 (one-way ANOVA with Bonferroni’s multiple comparison test; independent
cultures, n 4 in C and n 3 in D). E, Densitometric analysis and representative Western blot images of BAX and actin from
cytosol-enriched fractions obtained after 8 h of low K. The densitometric values of BAX bands were normalized to the corre-
sponding actin bands. Values are mean SEM. *p	 0.05, significantly different from the respective control (one-way ANOVA
with Bonferroni’s multiple comparison test, n 6 independent cultures).
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after NP1 knockdown in low potassium-treated wild-type CGNs
is mediated through BAX.
To determine whether the changes in mitochondrial length
observed after treatment with lowK and inBax knock-outmice
are associated with changes in individualmitochondrial mass, we
next studied the influence of NP1, BAX, and neuronal activity on
mitochondrial mass, an index integrating mitochondrial fission,
fusion, biogenesis, and degradation (Berman et al., 2009). Con-
sistent with the results observed for mitochondrial length, treat-
ment of wild-type CGNs with low potassium caused a marked
reduction of mitochondrial mass, and this effect was prevented
by NP1 knockdown (Fig. 8B). The effect of low potassium on
mitochondrial mass was not found in CGNs from Bax knock-out
mice, which already showed a significantly reduced mitochon-
drial mass compared with wild-type controls. These results pro-
vide additional evidence indicating that NP1 cooperates with
BAX to regulate mitochondrial dynamics during apoptosis.
NP1 interacts with BAX and colocalizes with active BAX
in mitochondria
The interaction of BAX with its putative partner proteins of the
BCL2 family can be induced in vitro by nonionic detergents that
expose the 6A7 N-terminal epitope of BAX associated with its
active conformation (Hsu and Youle, 1997). To investigate a pos-
sible interaction between BAX andNP1, we performed immuno-
precipitation studies with a 6A7 antibody in detergent lysates of
both native and recombinant BAX and NP1 proteins. We found
that NP1 coimmunoprecipitates with BAX in Triton X-100 ly-
sates from rat brain tissue (Fig. 9A). Similarly, coimmunoprecipi-
tation of BAX and NP1 was detectable in Triton X-100 lysates of
CGNs treated with low K for 2 h (Fig. 9B). Likewise, in HEK
293T cells expressing recombinant Bax and NP1, BAX coimmu-
noprecipitatedNP1 in Triton X-100 lysates (Fig. 9C). In contrast,
we could not detect BAX after immunoprecipitation of NP1 in
Triton X-100 lysates from rat brain tissue, CGNs, or HEK 293T
cells expressing the recombinant NP1–BAX proteins (results not
shown). The inability of NP1 antibody to immunoprecipitate the
BAX–NP1 complex could be because its epitope is occupied
when NP1 is complexed with BAX or because NP1 only interacts
with a fraction of BAX in a subcellular compartment. To test the
latter possibility, we performed immunoprecipitation experi-
ments in subcellular fractions treatedwith CHAPS, a zwitterionic
detergent that preserves BAX conformation (Hsu and Youle,
1997). However, we found that, in the presence of CHAPS, the
NP1 antibody does not immunoprecipitate NP1 (results not
shown). Although these results suggest that NP1 is capable of
interacting with BAX, the detergent conditions required for the
immunoprecipitation experiments do not allow the study of
whether this interaction occurs in a physiological condition. To
overcome this limitation, we assessed whether NP1 and BAX are
associated in immunocytochemistry studies.
To examine whether BAX and NP1 are associated in mito-
chondria, we performed studies in CGNs transduced with mito-
chondrially targeted MtDsRed, in conjunction with double
immunostaining with 6A7 and NP1 antibodies to identify active
BAX and NP1, respectively (Fig. 9D). After 4 h of treatment with
low K, confocal images of CGNs reveal that the soma of cells
undergoing apoptosis exhibit large clusters of active BAX that
colocalize withMtDsRed-labeledmitochondria.Moreover, most
of the mitochondria also exhibit NP1 immunofluorescence that
at least partially overlaps with the active BAX (Fig. 9D).
Figure 8. Influence of NP1 and Bax on mitochondrial fragmentation evoked by low K.
CGNs obtained from Bax wild-type and knock-out mice were transduced with control (shRan-
dom) or with the NP1 silencing lentiviral vector (shNP1) on DIV0 and treated with high or low
K for 6 h on DIV7. A, Influence of NP1 on mitochondrial length in Baxwild types and knock-
outs in response to low K. Mitochondria were marked using MtDsRed, and mitochondrial
length was measured as described in Materials and Methods. Values are mean SEM. *p	
0.01, significantly different fromhigh K/shRandom Bax/; &p	 0.01, significantly differ-
ent from lowK/shRandom Bax/ (one-way ANOVAwith Bonferroni’smultiple comparison
tests, n at least 2 independent cultures, n 170–450 mitochondria at each treatment
condition).B,Mitochondrialmass in neurites fromBaxwild types and knock-outs in response to
lowK and knockdownof NP1.Mitochondriaweremarked usingMtDsRed, andmitochondrial
mass was measured as described in Materials and Methods. Values are mean SEM. *p	
0.01, significantly different fromhigh K/shRandom Bax/; &p	 0.01, significantly differ-
ent from lowK/shRandom Bax/ (one-way ANOVAwith Bonferroni’smultiple comparison
tests, n at least 2 independent cultures, n 40–80 mitochondria at each treatment con-
dition).C, Representative imagesofMtDsRed-markedmitochondria inCGNs fromBaxwild-type
mice transduced with either shRandom or shNP1 and treated with either high K or low K
compared with CGNs from Bax knock-outs transduced with shRandom andmaintained in high
K. Scale bar, 2m.
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Discussion
We have investigated the place of NP1 within the cascade of
biochemical events of themitochondrial apoptosis program.Our
findings showing that NP1 facilitates translocation of BAX to
mitochondria and regulates mitochondrial dynamics represent
new evidence of a non-BCL-2 protein that interacts with BAX
and provide novel molecular insight into the mechanism that
links the intrinsic program of apoptosis with activity in neurons.
Moreover, the observation that NP1 accumulates in mitochon-
dria after induction of apoptosis in which it regulates mitochon-
drial fragmentation provides new evidence for an intracellular
function of NP1.
In contrast with non-neuronal cell lineages in which there is
functional redundancy among multidomain pro-apoptotic pro-
teins of the BCL-2 family, our results confirm previous evidence
showing that CGNs require the presence of BAX alone to un-
dergo programmed cell death (Miller et al., 1997). This substan-
tiates the use of the activity-dependent cell death model of CGNs
in culture as a reliablemodel to study the influence of NP1 on the
regulation of the BAX-dependent intrinsic program of apoptosis.
In this model, our data show that NP1 causes apoptosis by acti-
vating mechanisms of the intrinsic program of cell death, such as
BAX, cytochrome c release, and caspase-3 (Figs. 6, 7), and that
this pro-apoptotic effect of NP1 absolutely requires the presence
of BAX. Consequently, these results place NP1 overexpression
upstream or in parallel with the activation and/or translocation
of BAX to mitochondria.
We found that, during induction of the apoptosis program by
low activity, newly synthesized NP1moves to mitochondria. The
finding that treatment of CGNs with low K increases the
amount of NP1 in mitochondria was unexpected because NP2,
another member of the same family of pentraxins, has a func-
tional N-terminal secretion signal (Tsui et al., 1996). However,
several converging lines of evidence indicate thatmost of theNP1
induced by low K is targeted to mitochondria. First, despite the
marked increase in the expression of NP1 caused by low K, we
could not detect NP1 released by CGNs in the culture medium.
Moreover, biotinylation experiments that label proteins with res-
idues on the extracellular side of the neuronal membrane indi-
cated that the majority of NP1 is intracellular and that only a
small fraction of NP1 (5–8%) is located at the neuronal mem-
brane either before or after treatment of CGNs with low K.
These results are consistent with recent data showing that recep-
tor proteins of the neuronal pentraxin family have an intracellu-
lar function (Tseng and Bixby, 2011). Furthermore, biochemical
subcellular fractionation studies confirmed that NP1 induced by
low K is preferentially located at the mitochondria-enriched
subcellular fraction. Likewise, confocal immunofluorescence
analyses of NP1 confirm that, in control CGNs, NP1 is in
cytoplasmic puncta not associated with the cell membrane,
whereas NP1 increases markedly in mitochondria after treat-
ment with low K (Fig. 1). In accordance with these findings,
substitution of the first 80 amino acids of the NP1 N-terminal
side with the corresponding amino acids of NP2 produces a
recombinant hybrid protein that, when expressed in HEK
293T cells, is found preferentially in the cytosol rather than in
the mitochondria-enriched subcellular fraction (results not
shown). Overall, these results provide converging evidence to
indicate that, after the induction of the intrinsic program of
apoptosis by low neuronal activity in CGNs, the majority of
NP1 is targeted to the mitochondria.
We next performed a series of studies aimed at identifying the
functional effect of the increase of NP1 in mitochondria. We
found thatNP1 increases the number of cells with active BAX and
contributes to the accumulation of BAX tomitochondria (Fig. 7).
These results are consistent with the coincidence of time course
between the expression of NP1 and the translocation of BAX to
mitochondria, which both peak at 4 h after exposure to lowK in
CGNs (McGinnis et al., 1999; DeGregorio-Rocasolano et al.,
2001). The maximum level of NP1 expression and BAX translo-
cation to mitochondria lag behind but are near the time of peak
Figure 9. BAX immunoprecipitates NP1 and NP1 colocalizes with active BAX in mitochon-
dria.A–C, RepresentativeWestern blots of total protein lysate (TL), the eluate of BAX immuno-
precipitation (IP; Bax), and the eluate of IgG immunoprecipitation controls (IgG). A,
Immunoprecipitation of BAX from total brain lysates. Rat brains were homogenized, and pro-
tein lysates prepared as described in Materials and Methods. B, Immunoprecipitation of BAX
from CGN lysates. CGNs were treated with low K for 2 h. C, Immunoprecipitation of BAX from
HEK 293T cell lysates transfectedwith recombinant rat Bax and NP1 cDNAs.D, Confocalmicros-
copy studieswere performed inmature CGNs in culture after 4 h of K deprivation. Orthogonal
sectioning shows colocalization between NP1 and active BAX in mitochondria. Colocalization
between NP1 andMtDsRed is seen as yellow, between NP1 and BAX as cyan, and between BAX
andMtDsRedasmagenta, and colocalizationbetweenall threeproteins is shown inwhite. Scale
bar, 5m.
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expression of bim (Putcha et al., 2001) and the point of commit-
ment of CGNs to death, which occurs approximately between 5
and 6 h after treatment with low K (Enguita et al., 2005). Be-
cause neither NP1 overexpression nor NP1 knockdown modify
bims expression or BIMEL protein levels evoked by low K
 (re-
sults not shown), the present data indicate that the effect of NP1
occurs after the increase in BIM expression and before the accu-
mulation of BAX in mitochondria. The mechanisms of BAX
translocation and activation are still under investigation andmay
vary depending on cell type. The majority of BAX is soluble,
resides in the cytoplasm in healthy cells, and, during induction of
apoptosis, translocates to the mitochondria (Youle and Strasser,
2008). The finding reported here that knockdown of NP1 pre-
vents the increase in mitochondrial BAX evoked by low K (Fig.
7) indicates thatNP1 acts upstreamof BAXand contributes to the
activity-dependent process of BAX activation and accumulation
in themitochondria inCGNs.Moreover, the results showing that
BAX coimmunoprecipitates NP1, both the endogenous protein
from brain tissue and cultured CGNs, as well as recombinant
BAX (Fig. 9), suggest thatNP1 forms a protein complexwithBAX
that facilitates its activation and accumulation in mitochondria.
In support of this interpretation, our data from confocal immu-
nofluorescence analyses show that NP1 colocalizes with clusters
of active BAX in mitochondria (Fig. 9).
In addition to its role in apoptosis, BAX regulates mitochon-
drial fusion–fission dynamics through a direct interaction with
proteins involved in mitochondrial morphogenesis (Sheridan et
al., 2008; Cleland et al., 2011; Hoppins et al., 2011). Based on our
finding that NP1 interacts with BAX, we investigated the influ-
ence of NP1 onmitochondrial length andwe found that NP1 also
regulates activity-dependent mitochondrial dynamics. Exposure
of CGNs to low K increased the number of NP1 puncta at
putativemitochondrial scission sites and significantly reduced by
30–40% neuritic mitochondrial length (Fig. 2). Knockdown of
NP1 blocked this fragmentation (Figs. 3, 8), showing that NP1 is
required for the mitochondrial fragmentation evoked by low ac-
tivity. Based on these results, we next sought to determine
whether the effect of NP1 on mitochondrial dynamics is BAX
dependent. Thus, we studied the influence of NP1 and BAX on
mitochondrial length in cultured CGNs frommice with different
gene dosages of Bax. In agreement with the results reported in
Figures 2A and 3C that were obtained in cultured rat CGNs,
treatment of wild-type mouse CGNs with low K caused a
marked reduction in mitochondrial length and mass. These ef-
fects were completely blocked by the knockdown of NP1 (Fig. 8),
confirming that NP1 is required for mitochondrial fragmenta-
tion caused by low neuronal activity. Moreover, consistent with
previous studies (Karbowski et al., 2006), mitochondria in CGNs
from Bax knock-out mice were fragmented, and, in these cells,
induction of apoptosis by low K did not lead to an additional
reduction in mitochondrial length (Fig. 8). In addition, knock-
down of NP1 did not prevent the mitochondrial fragmentation
observed in Bax knock-out mice. These results indicate that NP1
contributes to mitochondrial fragmentation during apoptosis by
facilitating the activation of BAX and neutralizing in turn the
positive effect that soluble BAX has on mitochondrial fusion in
healthy cells (Hoppins et al., 2011). This interpretation is consis-
tent with the mechanistic model that proposes a mutually exclu-
sive relationship between the role of BAX in the positive
regulation of mitochondrial fusion and its role in apoptosis
(Sheridan et al., 2008; Cleland et al., 2011; Hoppins et al., 2011).
Overall, the present results indicate that NP1 is required for mi-
tochondrial fragmentation during apoptosis and suggest that
activity-dependent regulation of NP1 expression is part of a
mechanism that transforms the physiological action of proteins
that regulate mitochondrial dynamics in healthy cells such as
BAX into a pathological pro-apoptotic function.
In neurons, mitochondrial length may also influence subcel-
lular mitochondrial distribution; the transport of mitochondria
to synapses in which there is a high energy demand is essential for
neuronal viability. We found that, in addition to its effect on
mitochondrial morphology, NP1 reduces anterograde, but not
retrograde, movement of mitochondria without altering their
velocity (Fig. 4). Other pro-apoptotic proteins associated with
neurodegenerative diseases, such as mutant forms of Huntingtin
and superoxide dismutase as well as A, have been reported to
induce mitochondrial fragmentation and impair mitochondrial
trafficking (for review, see Rintoul and Reynolds, 2010). Al-
though the relationship between mitochondrial dynamics and
transport is still not well understood, the observation that NP1
interacts with BAX, which interacts in turn with Mitofusin 2
(Hoppins et al., 2011), a protein that is necessary for mitochon-
drial transport throughMiro 1, a GTPase localized in mitochon-
dria (Misko et al., 2010), suggests that NP1 may interfere with
anterograde transport by preventing the association of BAX with
the Miro/Milton protein complex. This hypothesis is currently
under investigation.
In summary, we report that the intrinsic program of neuronal
apoptosis evoked by low neuronal activity depends on the over-
expression ofNP1 that is targeted tomitochondria. The increased
expression of NP1 during apoptosis occurs upstream of BAX and
facilitates the activation and accumulation of BAX in mitochon-
dria. Moreover, NP1 regulates mitochondrial trafficking and is
necessary for mitochondrial fragmentation evoked by low neu-
ronal activity. These data provide evidence for a novel function
for NP1 in the regulation of mitochondrial dynamics and traf-
ficking and indicate that NP1 expression and targeting to the
mitochondria during apoptosis is part of the mechanism by
which lowneuronal activity regulates themitochondrial program
of apoptosis. Moreover, because NP1 is markedly increased in
brain tissue from patients with late-onset Alzheimer’s disease
(Abad et al., 2006), the present results may be of importance in
understanding the mechanisms of neuronal dysfunction in
chronic neurodegenerative disorders that have been associated
with alterations in mitochondrial function.
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